Northern Oil and Gas, Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $3.5 Billion | 7/14 | AR $12.3B |
MTDR $7.0B |
CRK $5.2B |
CIVI $4.7B |
MGY $4.4B |
MUR $4.0B |
NOG $3.5B |
ESTE $3.0B |
CPE $2.4B |
SBOW $940.4M |
EGY $441.4M |
PHX $154.8M |
EPSN $132.2M |
PDCE $0 |
Gross Margin | 100% | 1/14 | NOG 100% |
AR 100% |
PDCE 100% |
EGY 100% |
MUR 99% |
CIVI 99% |
EPSN 93% |
ESTE 91% |
CRK 84% |
CPE 83% |
PHX 54% |
SBOW 38% |
MGY 6% |
MTDR 0% |
Profit Margin | 40% | 1/14 | NOG 40% |
PDCE 33% |
MGY 30% |
CPE 28% |
MTDR 28% |
ESTE 26% |
CIVI 23% |
MUR 18% |
PHX 12% |
EGY 8% |
EPSN 5% |
SBOW -6% |
AR -8% |
CRK -22% |
EBITDA margin | 72% | 1/14 | NOG 72% |
EGY 64% |
SBOW 64% |
CPE 56% |
PHX 50% |
MGY 50% |
PDCE 48% |
EPSN 48% |
CIVI 48% |
MUR 46% |
CRK 45% |
MTDR 43% |
ESTE 41% |
AR 5% |
Quarterly Revenue | $753.6 Million | 5/14 | CIVI $1.3B |
AR $1.2B |
MTDR $894.1M |
PDCE $871.8M |
NOG $753.6M |
MUR $753.2M |
CPE $601.4M |
ESTE $475.8M |
MGY $333.1M |
SBOW $256.7M |
CRK $253.6M |
EGY $140.3M |
PHX $9.1M |
EPSN $7.3M |
Quarterly Earnings | $298.4 Million | 1/14 | NOG $298.4M |
CIVI $295.8M |
PDCE $288.7M |
MTDR $248.3M |
CPE $169.0M |
MUR $139.1M |
ESTE $125.0M |
MGY $99.8M |
EGY $11.0M |
PHX $1.1M |
EPSN $366,021 |
SBOW -$15.5M |
CRK -$55.1M |
AR -$92.9M |
Quarterly Free Cash Flow | $0 Million | 14/14 | MUR $945.9M |
CRK $686.4M |
CIVI $396.6M |
AR $278.0M |
MTDR $185.8M |
SBOW $121.3M |
MGY $103.2M |
EGY $96.9M |
CPE $80.3M |
PHX $2.8M |
PDCE $268,000 |
EPSN $260,813 |
ESTE -$728.8M |
NOG -$0 |
Trailing 4 Quarters Revenue | $2.6 Billion | 7/14 | PHX $37.6T |
CIVI $5.0B |
AR $4.3B |
PDCE $4.2B |
MTDR $3.4B |
MUR $3.2B |
NOG $2.6B |
CPE $1.8B |
ESTE $1.8B |
MGY $1.3B |
CRK $1.2B |
SBOW $769.1M |
EGY $506.4M |
EPSN $31.1M |
Trailing 4 Quarters Earnings | $837.5 Million | 5/14 | CIVI $1.3B |
AR $1.2B |
MTDR $894.1M |
PDCE $871.8M |
NOG $753.6M |
MUR $753.2M |
CPE $601.4M |
ESTE $475.8M |
MGY $333.1M |
SBOW $256.7M |
CRK $253.6M |
EGY $140.3M |
PHX $9.1M |
EPSN $7.3M |
Quarterly Earnings Growth | 1043% | 2/14 | PHX 2765% |
NOG 1043% |
CIVI 112% |
EGY 79% |
MGY -2% |
MTDR -6% |
EPSN -6% |
CPE -38% |
ESTE -41% |
MUR -46% |
PDCE -56% |
SBOW -116% |
AR -127% |
CRK -474% |
Annual Earnings Growth | 58% | 6/14 | PHX 48642629% |
EGY 243% |
PDCE 227% |
EPSN 214% |
CIVI 78% |
NOG 58% |
CRK 27% |
MTDR 16% |
MGY 0% |
MUR -3% |
ESTE -30% |
SBOW -69% |
CPE -79% |
AR -136% |
Quarterly Revenue Growth | 140% | 1/14 | NOG 140% |
SBOW 83% |
CIVI 23% |
PHX 21% |
MTDR 16% |
EPSN 15% |
EGY 13% |
MGY 6% |
ESTE -10% |
CPE -15% |
AR -19% |
MUR -21% |
PDCE -23% |
CRK -33% |
Annual Revenue Growth | 69% | 3/14 | PHX 67821615% |
PDCE 100% |
NOG 69% |
CIVI 67% |
MTDR 25% |
EPSN 21% |
MGY 13% |
EGY 12% |
SBOW 4% |
CRK 0% |
MUR -6% |
AR -8% |
ESTE -10% |
CPE -43% |
Cash On Hand | $34.4 Million | 5/14 | MGY $276.1M |
MUR $271.2M |
EGY $89.1M |
CIVI $47.1M |
NOG $34.4M |
MTDR $23.3M |
ESTE $16.6M |
CRK $13.8M |
PDCE $10.2M |
EPSN $8.3M |
CPE $3.3M |
PHX $2.6M |
SBOW $1.4M |
AR -$0 |
Short Term Debt | $0 | 9/14 | AR $493.9M |
MUR $254.1M |
SBOW $45.3M |
CRK $35.4M |
EGY $12.9M |
ESTE $2.3M |
PHX $243,184 |
EPSN $112,502 |
NOG -$0 |
CPE -$0 |
PDCE -$0 |
MGY -$0 |
CIVI -$0 |
MTDR -$55.1M |
Long Term Debt | $2.0 Billion | 4/14 | AR $3.5B |
CRK $2.9B |
MTDR $2.1B |
NOG $2.0B |
CPE $1.9B |
MUR $1.9B |
ESTE $1.7B |
PDCE $1.5B |
SBOW $1.0B |
MGY $394.8M |
EGY $72.9M |
PHX $28.3M |
EPSN $385,653 |
CIVI $0 |
PE | 4.19 | 10/14 | EPSN 25.02 |
MGY 11.62 |
MTDR 7.61 |
MUR 7.54 |
ESTE 6.55 |
CPE 5.93 |
SBOW 5.01 |
EGY 4.88 |
CIVI 4.75 |
NOG 4.19 |
PHX 0.00 |
AR -1.00 |
PDCE -1.00 |
CRK -1.00 |
PS | 1.32 | 7/14 | EPSN 4.25 |
CRK 4.19 |
MGY 3.35 |
AR 2.84 |
MTDR 2.09 |
ESTE 1.70 |
NOG 1.32 |
CPE 1.30 |
MUR 1.26 |
SBOW 1.22 |
CIVI 0.93 |
EGY 0.87 |
PHX 0.00 |
PDCE -1.00 |
PB | 1.52 | 4/14 | MGY 2.06 |
CRK 1.86 |
AR 1.70 |
NOG 1.52 |
MTDR 1.45 |
EPSN 1.34 |
PHX 1.25 |
ESTE 1.15 |
EGY 0.88 |
SBOW 0.80 |
MUR 0.75 |
CIVI 0.71 |
CPE 0.60 |
PDCE 0.00 |
PC | 102.05 | 6/14 | CPE 715.29 |
SBOW 650.32 |
CRK 377.74 |
MTDR 302.43 |
ESTE 179.53 |
NOG 102.05 |
CIVI 99.95 |
PHX 59.50 |
EPSN 15.92 |
MGY 15.90 |
MUR 14.88 |
EGY 4.95 |
PDCE 0.00 |
AR -1.00 |
Liabilities to Equity | 1.19 | 5/14 | CRK 1.72 |
ESTE 1.41 |
SBOW 1.29 |
CIVI 1.25 |
NOG 1.19 |
MTDR 1.18 |
PDCE 0.89 |
EGY 0.87 |
AR 0.83 |
MUR 0.80 |
CPE 0.68 |
PHX 0.32 |
MGY 0.32 |
EPSN 0.24 |
ROA | 0.17 | 3/14 | PHX 8549588% | PDCE 22% | NOG 17% | MGY 13% | EGY 10% | MTDR 9% | ESTE 9% | SBOW 7% | CIVI 7% | CPE 6% | MUR 6% | EPSN 4% | AR -1% | CRK -1% |
ROE | 0.36 | 3/14 | PHX 11261603% |
PDCE 42% |
NOG 36% |
ESTE 25% |
MTDR 19% |
EGY 18% |
MGY 18% |
SBOW 16% |
CIVI 15% |
CPE 10% |
MUR 10% |
EPSN 5% |
AR -2% |
CRK -4% |
Current Ratio | 1.84 | 11/14 | EPSN 5.20 |
MGY 4.16 |
PHX 4.15 |
CPE 2.47 |
AR 2.25 |
MUR 2.25 |
EGY 2.15 |
PDCE 2.12 |
ESTE 2.01 |
MTDR 1.85 |
NOG 1.84 |
CIVI 1.80 |
SBOW 1.77 |
CRK 1.71 |
Quick Ratio | 0.01 | 6/14 | EPSN 25.02 |
MGY 11.62 |
MTDR 7.61 |
MUR 7.54 |
ESTE 6.55 |
CPE 5.93 |
SBOW 5.01 |
EGY 4.88 |
CIVI 4.75 |
NOG 4.19 |
PHX 0.00 |
AR -1.00 |
PDCE -1.00 |
CRK -1.00 |
Long Term Debt to Equity | 0.84 | 4/14 | CRK} 1.28 |
ESTE} 0.95 |
SBOW} 0.88 |
NOG} 0.84 |
AR} 0.50 |
CPE} 0.48 |
MTDR} 0.43 |
MUR} 0.35 |
PDCE} 0.34 |
PHX} 0.23 |
MGY} 0.18 |
EGY} 0.15 |
EPSN} 0.00 |
CIVI} 0.00 |
Debt to Equity | 0.84 | 4/14 | CRK 1.28 |
ESTE 0.95 |
SBOW 0.93 |
NOG 0.84 |
AR 0.57 |
CPE 0.48 |
MTDR 0.43 |
MUR 0.40 |
PDCE 0.34 |
PHX 0.23 |
MGY 0.18 |
EGY 0.17 |
EPSN 0.01 |
CIVI 0.00 |
Burn Rate | -0.16 | 9/14 | MUR 674.21 |
PHX 28.60 |
CRK 0.08 |
SBOW 0.02 |
AR 0.00 |
CPE -0.04 |
PDCE -0.04 |
MTDR -0.13 |
NOG -0.16 |
CIVI -0.16 |
ESTE -0.30 |
MGY -3.29 |
EGY -18.37 |
EPSN -25.75 |
Cash to Cap | 0.01 | 6/14 | EGY 0.20 |
MUR 0.07 |
MGY 0.06 |
EPSN 0.06 |
PHX 0.02 |
NOG 0.01 |
ESTE 0.01 |
CIVI 0.01 |
AR 0.00 |
CPE 0.00 |
MTDR 0.00 |
CRK 0.00 |
SBOW 0.00 |
PDCE |
CCR | 14/14 | EGY 8.82 |
MUR 6.80 |
PHX 2.51 |
CIVI 1.34 |
MGY 1.03 |
MTDR 0.75 |
EPSN 0.71 |
CPE 0.48 |
PDCE 0.00 |
AR -2.99 |
ESTE -5.83 |
SBOW -7.81 |
CRK -12.45 |
NOG |
|
EV to EBITDA | 9.93 | 11/14 | AR} 255.54 |
CRK} 71.75 |
PHX} 39.66 |
EPSN} 35.69 |
MGY} 26.93 |
ESTE} 24.07 |
MTDR} 23.62 |
MUR} 17.23 |
CPE} 12.68 |
SBOW} 12.42 |
NOG} 9.93 |
CIVI} 7.65 |
EGY} 4.87 |
PDCE} -1.00 |
EV to Revenue | 2.05 | 9/14 | CRK 6.55 |
EPSN 4.00 |
AR 3.77 |
MGY 3.44 |
MTDR 2.71 |
ESTE 2.67 |
SBOW 2.65 |
CPE 2.34 |
NOG 2.05 |
MUR 1.85 |
CIVI 0.92 |
EGY 0.87 |
PHX 0.00 |
PDCE -1.00 |